Article Information
History
- June 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Scott A. Scarneo1,#,
- Aaron P. Smith1,#,
- Jacob Favret2,
- Robert O’Connell2,
- Joy Pickeral3,
- Kelly W. Yang1,
- Guido Ferrari3,
- David R. Loiselle1,
- Philip F. Hughes1,
- Manjusha M Kulkarni4,
- Madhusudhana Gargesha5,
- Bryan Scott5,
- Debashish Roy5,
- Barton F. Haynes6,
- Jesse J. Kwiek4 and
- Timothy A. J. Haystead1,*
- 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710
- 2Bolder BioPath INC., Boulder, CO, 80301
- 3Department of Surgery, Duke University School of Medicine, Durham, NC 27710
- 4Department of Microbiology, Ohio State University, Columbus, OH 43210
- 5BioInVision, Inc., Mayfield Village, OH 44143
- 6Department of Medicine, Duke University School of Medicine, Durham, NC 27710
- ↵*Indicates Corresponding author Corresponding author
: Timothy Haystead, PhD, Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, 308 Research Drive, Durham NC 27710, Email: timothy.haystead{at}duke.edu, Phone: 919 613 8606